Atıf Formatları
The effect of concomitant immunosuppressive drug use on tuberculosis risk among anti-TNF-α users due to rheumatologic conditions
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

V. Aydın Et Al. , "The effect of concomitant immunosuppressive drug use on tuberculosis risk among anti-TNF-α users due to rheumatologic conditions," British Pharmacological Society (BPS) , London, England, pp.1, 2017

Aydın, V. Et Al. 2017. The effect of concomitant immunosuppressive drug use on tuberculosis risk among anti-TNF-α users due to rheumatologic conditions. British Pharmacological Society (BPS) , (London, England), 1.

Aydın, V., Bayram, D., Aksoy, M., & Akıcı, A., (2017). The effect of concomitant immunosuppressive drug use on tuberculosis risk among anti-TNF-α users due to rheumatologic conditions . British Pharmacological Society (BPS) (pp.1). London, England

Aydın, Volkan Et Al. "The effect of concomitant immunosuppressive drug use on tuberculosis risk among anti-TNF-α users due to rheumatologic conditions," British Pharmacological Society (BPS), London, England, 2017

Aydın, Volkan Et Al. "The effect of concomitant immunosuppressive drug use on tuberculosis risk among anti-TNF-α users due to rheumatologic conditions." British Pharmacological Society (BPS) , London, England, pp.1, 2017

Aydın, V. Et Al. (2017) . "The effect of concomitant immunosuppressive drug use on tuberculosis risk among anti-TNF-α users due to rheumatologic conditions." British Pharmacological Society (BPS) , London, England, p.1.

@conferencepaper{conferencepaper, author={Volkan Aydın Et Al. }, title={The effect of concomitant immunosuppressive drug use on tuberculosis risk among anti-TNF-α users due to rheumatologic conditions}, congress name={British Pharmacological Society (BPS)}, city={London}, country={England}, year={2017}, pages={1} }